tirzepatide and dementia Tirzepatide: a novel therapeutic approach for Alzheimer's disease GLP-1 Agonists Linked to Lower

Patients and providers should be made aware of adverse CVEs in future studies, and pharmacologic and non-pharmacologic approaches should be examined to reduce NAFLD and adverse CVEs in individuals with type 2 diabetes

16 Ludvik, B., et al., Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial

doi: 10.1016/s0301-0082(00)00067-8 64

People with a personal or family history of medullary cell carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2) should avoid semaglutide

Effects of Caffeine on Parkinsons Disease Parkinsons disease (PD) is a chronic, progressive neurological disease that causes bradykinesia, slow movements, postural instability, and rigidity [89]